Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
Pitiyarachchi O, Ansell PJ, Coleman RL, Dinh MH, Holman L, Leath CA 3rd, Werner T, DiSilvestro P, Morgan M, Tew W, Lee C, Cunningham M, Newton M, Edraki B, Lim P, Barlin J, Spirtos NM, Tewari KS, Edelson M, Reid T, Carlson J, Friedlander M.
Pitiyarachchi O, et al. Among authors: edelson m.
Gynecol Oncol. 2024 May 30;187:221-226. doi: 10.1016/j.ygyno.2024.05.021. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 38821039
Free article.